TRANSPLANT OUTCOMES IN PATIENTS WITH DE NOVO DONOR SPECIFIC ANTIBODIES POST TRANSPLANT

被引:1
|
作者
Pochinco, Denise [1 ]
Kelm, Dawn [1 ]
Kendra, Hacking [1 ]
Blydt-Hansen, Tom [2 ]
Rush, David [2 ]
Gibson, Ian [2 ]
Nickerson, Peter [2 ]
机构
[1] DSM, Transplant Immunol Lab, Winnipeg, MB, Canada
[2] Univ Manitoba, Fac Med, Winnipeg, MB, Canada
关键词
D O I
10.1016/j.humimm.2009.09.139
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:S65 / S65
页数:1
相关论文
共 50 条
  • [1] Outcomes of De Novo Donor Specific Antibodies in Pancreas Transplant Recipients.
    Parajuli, S.
    Alagusundaramoorthy, S.
    Aziz, F.
    Garg, N.
    Redfield, R.
    Sollinger, H.
    Kaufman, D.
    Djamali, A.
    Odorico, J.
    Mandelbrot, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 432 - 432
  • [2] Outcomes of Pancreas Transplant Recipients With De Novo Donor-specific Antibodies
    Parajuli, Sandesh
    Alagusundaramoorthy, Sayee
    Aziz, Fahad
    Garg, Neetika
    Redfield, Robert R.
    Sollinger, Hans
    Kaufman, Dixon
    Djamali, Arjang
    Odorico, Jon
    Mandelbrot, Didier
    TRANSPLANTATION, 2019, 103 (02) : 435 - 440
  • [3] Outcomes in Kidney Transplant Recipients That Develop De Novo Donor Specific Antibodies
    DeVos, J. M.
    Patel, S. J.
    Land, G.
    Knight, R. J.
    Achkar, K.
    Dilioglou, S.
    Dawson, K. L.
    Abdellatif, A.
    Gaber, A. O.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 294 - 294
  • [4] Development of De Novo Donor Specific Antibodies after Post-Transplant UTI
    Morgenstern, B.
    Joseph, M.
    Hsieh, S.
    Papez, K.
    Dvorchik, I.
    PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1894 - 1894
  • [5] Risk of Post-Transplant De Novo Donor Specific Antibodies in Patients Receiving Transfusions Perioperatively
    Mahoney, I.
    Young, A.
    Shekiladze, N.
    Morris, A.
    Gupta, D.
    Bhatt, K.
    Laskar, S.
    Smith, A.
    Vega, J.
    Cole, R. T.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S423 - S424
  • [6] Patients Bridged to Transplant with Durable LVAD Support Have a Higher Risk of Post-Transplant De Novo Donor Specific Antibodies
    Cole, R. T.
    Minto, J.
    Bogar, L.
    Miller, H.
    Morris, A.
    Gupta, D.
    Smith, A.
    Vega, J.
    Laskar, S.
    Bhatt, K.
    Shah, P.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S150 - S151
  • [8] Incidence of De Novo Donor Specific Antibodies in Kidney Transplant Recipients
    Staino, C.
    Pilch, N.
    Moussa, O.
    Boyle, K.
    Casale, J.
    Covert, K.
    Fleming, J.
    Taber, D.
    Meadows, H.
    Mardis, C.
    Chavin, K.
    Nadig, S.
    McGillicuddy, J.
    Bratton, C.
    Srinivas, T.
    Baliga, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [9] Donor specific antibodies in post lung transplant patients
    Pang, S.
    Phelan, D.
    Trulock, E.
    Mohanakumar, T.
    HUMAN IMMUNOLOGY, 2006, 67 (10) : S175 - S175
  • [10] The impact of early de novo donor-specific antibodies on lung transplant outcomes: Is timing everything?
    King, Christopher S.
    Cochrane, Adam B.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (09): : 1057 - 1058